Abstract
Cell therapy technologies and methods have already started to play an
important role in the practice of medicine. Hematopoietic stem cell
transplantation is replacing the old fashioned bone marrow transplants. Cell
therapy is bound to become a part of medical practice. Unlike organs, cells
are a potentially renewable resource for body repair. The goal of this TriMark
Publications report is to review the market for cell therapy products using
screening reagents and instruments for analysis of individual components in
tissue samples, blood, serum or plasma. It defines the dollar volume of sales,
both worldwide and in the U.S., and analyzes the factors that influence the
size and the growth of the market segments. Also examined are the subsections
of each market segment, including the research labs, hospital labs and
commercial laboratories. Additionally, the numbers of institutions using this
type of cell therapy and the factors that influence purchases are discussed.
The study surveys almost all of the companies known to be marketing,
manufacturing or developing instruments and reagents for the cell therapy
market in the U.S. Each company is discussed in extensive depth with a section
on its history, product line, business and marketing analysis, and a
subjective commentary of the company' s market position.
View Cart
